3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
27
Carcinoma, Non-Small-Cell Lung
27
Brain Neoplasms
23
Lung Neoplasms
17
Neoplasm Metastasis
15
Breast Neoplasms
12
Melanoma
9
Carcinoma, Renal Cell
8
Pancreatic Neoplasms
7
Colorectal Neoplasms
6
Carcinoma, Hepatocellular
5
Urinary Bladder Neoplasms
3
Neoplasms
3
NSCLC
3
Meningioma
3
Gastrointestinal Neoplasms
3
Unresectable Locally Recurrent Rectal Cancer
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Spinal Cord Compression
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Epidural Neoplasms
2
Carcinoma, Transitional Cell
2
Adenocarcinoma
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Interventions
Gemcitabine
8
Cisplatin
8
pembrolizumab
4
durvalumab
4
Specimen Handling
3
Platinum
3
Oxaliplatin
3
Leucovorin
3
1,2-diaminocyclohexaneplatinum II citrate
3
Taxes
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Folfox protocol
2
Fluorouracil
2
Biopsy
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
zanidatamab
1
trastuzumab deruxtecan
1
tivozanib
1
peposertib
1
guadecitabine
1
fludarabine
1
dehydroftorafur
1
binimetinib
1
avelumab
1
atezolizumab
1
Trastuzumab
1
Radiation Dose Hypofractionation
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Radiosurgery
×
90 days
×
Clear all
No trials found.